Openbookopenbook
Equity
Identa Corp(IDTA)
USD --+0.00%
Reward37Moderate
Risk57Medium-High
📊75%Data
Thin -5% profit margin · Revenue growing 17% YoY
IDTA
+0.0 · +0.00%
USD · OTCQB
Identa Corp | Healthcare
Value Trap
Market Cap:1.10M
ℹ️
Reward Rating
37
Moderate
Bottom 5% (model universe)
75% data coverage
ℹ️
Risk Rating
57
Medium-High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on IDTA to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Identa Corp?

operates as a detection and forensic science company.

IDTA · Verdict

Limited reward · elevated risk

IDTA's standout is volatility; growth and cash flow weigh on the picture.

Based on 88% data coverage

IDTA · Verdict

What’s working & what to watch

Strengths 1

  • Volatility80/100

    Top decile vs peers

Watchouts 3

  • Growth13/100

    Rev -10.2% CAGR · earnings -65.4%

  • Cash flow25/100

    -14% free-cash-flow margin

  • Balance sheet38/100

    Current ratio 4.76

Model-based scoring. For information only — not financial advice.

What is Identa Corp?

operates as a detection and forensic science company. The company offers drug testing kits, explosives testing kits, aero chamber sniffer, forensic, urine drug testing, and saliva drug testing products. The company is listed on the OTCQB in USA, operating in the Healthcare sector, with a market capitalisation of 1.10M, and a P/E ratio of 2.7x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Moderate volatility with meaningful macro and earnings sensitivity.
💸 Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (37)

The scoring profile indicates weak reward characteristics across most factors, including profitability and valuation. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap1.10M
P/E Ratio2.72
Dividend YieldN/A
52 Week High0.75
52 Week Low0.152
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding4M
No. of Employees11
IndustryDiagnostics & Research
ExchangeOTCQB
Beta0.571
CurrencyUSD
Websitewww.identa-corp.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.